Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
-
-
-
-
-
-
Deutsche Bank Reiterates Buy Rating on Eli Lilly (LLY) Amid New U.S. Investment
-
-
-
-
-
-
-
Deutsche Bank Comments on Eli Lilly (LLY)
-
-
-
-
-
-
-
Pre-Open Stock Movers 06/24: (MRIN) (RCUS) (LLY) Higher; (PRTG) (RAD) (BIIB) Lower (more...)
-
-
-
-
-
-
-
Lilly's (LLY) Subsidiary Elanco Animal Health's (ELAN) IPO Prices at $24/Share
-
-
-
-
-
-
-
Eli Lilly (LLY) PT Raised to $91 at Deutsche Bank
-
-
-
-
-
-
-
Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities
-
-
-
-
-
-
-
Notable Analyst Rating Changes 01/10: (MSFT) (INCY) (TGT) Upgraded; (LLY) (AMBA) (CUDA) Downgraded
-
55,959 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

